Thus, to improve clinical management of BRCA1 and BRCA2 mutation carriers is necessary a deep knowledge concerning the impact of modifiable factors, as obesity, on BC risk, that may provide the oncologists additional recommendations for the care of patients with BC. This evidence concerns the gene BRCA2 and obesity disorder.